GlassScriptPhysician profile
Koroush Khalighi
NPI 1356345193
$9,001.62
in general payments reported to CMS, 2019-2025
16 companies · $481 in 2025
The $481 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,182 · 2020: $151 · 2021: $2,184 · 2022: $230 · 2023: $1,381 · 2024: $2,393 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,145 · Food and Beverage: $2,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,145.16 |
| Food and Beverage | $2,109.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $5,696.04 | 2019-2024 | Edora 8 Dr-T, Rivacor 7 Dr-T |
| Boston Scientific Corporation | $1,567.33 | 2019-2022 | |
| Scpharmaceuticals INC. | $374.22 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $247.57 | 2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $163.68 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $124.74 | 2024 | Lokelma |
| Novo Nordisk INC | $124.74 | 2024 | Wegovy |
| Lexicon Pharmaceuticals, INC. | $124.74 | 2024 | Inpefa |
| Impulse Dynamics (USA) INC. | $124.38 | 2021 | |
| Amgen INC. | $110.08 | 2020-2022 | |
| Endologix LLC | $106.52 | 2025 | Alto Abdominal Stent Graft System |
| Abiomed | $73.45 | 2023-2024 | Impella |
| Alnylam Pharmaceuticals INC. | $71.73 | 2022 | |
| Philips North America LLC | $48.59 | 2022 | |
| Sanofi-Aventis U.S. LLC | $23.19 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braemar Manufacturing, LLC | $20.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Koroush Khalighi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.